Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹148.38
Market cap: ₹8,131 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.9×Sector 47.4×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

4 Aug 2026 13:44 IST BSE

Morepen Laboratories Q1 FY27 Results: Net Profit ₹56.3 Cr, Up 393.9% YoY

Morepen Laboratories Ltd reported revenue from operations of ₹570.1 Cr (+34.1% YoY) and net profit of ₹56.3 Cr (+393.9% YoY) for Q1 FY27.

Key figure: Net profit ₹56.3 Cr · +393.9% YoY

Open full results → Read the filing ↗

26 May 2026 17:37 IST BSE

Financial Results

Morepen Laboratories Q4 FY26 Results: Net Profit ₹15.7 Cr, Down 22.7% YoY

Morepen Laboratories Ltd reported revenue from operations of ₹484.7 Cr (+4.0% YoY) and net profit of ₹15.7 Cr (-22.7% YoY) for Q4 FY26.

Key figure: Net profit ₹15.7 Cr · -22.7% YoY

Open full results → Read the filing ↗

26 May 2026 17:36 IST BSE

Financial Results

Morepen Laboratories Financial Results

Morepen Laboratories reported audited FY26 results and recommended a Rs. 0.20 per share final dividend. The board also revised the Medical Devices business transfer date.

Value: ₹0.20 Cr

Read the filing ↗